Xilio Therapeutics, Inc. (XLO) Operating income 2020–2025
Xilio Therapeutics, Inc. (XLO) annual operating income history from SEC filings — each fiscal year as reported.
-$42.0MFY2025 · since FY2020: -$54.6M → -$42.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$42.0M | +30.7% |
| FY2024 | -$60.6M | +23.4% |
| FY2023 | -$79.1M | +11.2% |
| FY2022 | -$89.1M | -18.8% |
| FY2021 | -$75.0M | -37.5% |
| FY2020 | -$54.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice